Liaoning Chengda Biotechnology Co.,Ltd.

XSSC:688739 주식 보고서

시가총액: CN¥11.2b

Liaoning Chengda BiotechnologyLtd 미래 성장

Future 기준 확인 0/6

Liaoning Chengda BiotechnologyLtd is forecast to grow revenue at 7.2% per annum.

주요 정보

n/a

수익 성장률

n/a

EPS 성장률

Biotechs 수익 성장44.8%
매출 성장률7.2%
향후 자기자본 수익률4.7%
애널리스트 커버리지

Low

마지막 업데이트10 Sep 2024

최근 미래 성장 업데이트

업데이트 없음

Recent updates

수익 및 매출 성장 예측

XSSC:688739 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (CNY Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/20262,034N/A3524941
12/31/20251,867N/A2994401
12/31/20241,771N/A3355101
9/30/20241,718332175526N/A
6/30/20241,759353116547N/A
3/31/20241,761420109602N/A
12/31/20231,750466125677N/A
9/30/20231,78958895678N/A
6/30/20231,805667120659N/A
3/31/20231,802690135617N/A
12/31/20221,81571435546N/A
9/30/20221,71365366583N/A
6/30/20221,79769828573N/A
3/31/20221,859763-2572N/A
12/31/20212,088892-2506N/A
9/30/20212,069916-34414N/A
6/30/20212,138970216557N/A
3/31/20212,091942464735N/A
12/31/20201,996918671860N/A
9/30/20202,0589197921,065N/A
6/30/20201,970899610998N/A
3/31/20201,895817354774N/A
12/31/20191,677698262724N/A
9/30/20191,532713284658N/A
6/30/20191,461650381620N/A
3/31/20191,425650463637N/A
1/1/20191,391627532640N/A
9/30/20181,418612567627N/A
6/30/20181,357593N/A637N/A
3/31/20181,308579N/A688N/A
12/31/20171,276556N/A644N/A
9/30/20171,278577N/A552N/A
6/30/20171,146482N/A592N/A
3/31/20171,011429N/A484N/A
12/31/20161,030457N/A525N/A
9/30/2016925410N/A556N/A
6/30/2016904447N/A436N/A
3/31/2016924452N/A460N/A
12/31/2015943458N/A484N/A
9/30/2015964475N/A460N/A
6/30/2015978478N/A583N/A
3/31/2015957460N/A630N/A
12/31/2014937442N/A678N/A
12/31/2013851404N/A406N/A

애널리스트 미래 성장 예측

수입 대 저축률: Insufficient data to determine if 688739's forecast earnings growth is above the savings rate (2.9%).

수익 vs 시장: Insufficient data to determine if 688739's earnings are forecast to grow faster than the CN market

고성장 수익: Insufficient data to determine if 688739's earnings are expected to grow significantly over the next 3 years.

수익 대 시장: 688739's revenue (7.2% per year) is forecast to grow slower than the CN market (14% per year).

고성장 수익: 688739's revenue (7.2% per year) is forecast to grow slower than 20% per year.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: 688739's Return on Equity is forecast to be low in 3 years time (4.7%).

성장 기업 발견

7D

1Y

7D

1Y

7D

1Y